FDA Inspection 1289850 — Trifarma S.p.A.
The FDA completed an inspection of Trifarma S.p.A. on September 27, 2024 in Rozzano. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- September 27, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Rozzano (Italy)
Additional Details
Mutual Recognition Agreement (MRA)